Literature DB >> 14697498

Role of tumor necrosis factor receptor-1 in the death of retinal ganglion cells following optic nerve crush injury in mice.

Gülgün Tezel1, Xiangjun Yang, Junjie Yang, Martin B Wax.   

Abstract

To assess the specific role of tumor necrosis factor (TNF) death receptor signaling in the induction of retinal ganglion cell (RGC) death, optic nerves of mice deficient for TNF receptor-1 (TNF-R1-/-) and control mice (C57BL/6J) were unilaterally subjected to crush injury. Counts of RGCs and their axons 6 weeks after the injury demonstrated that their loss was significantly less in TNF-R1-/- mice compared to controls. The most prominent decrease in neuronal loss detected in TNF-R1-/- mice was beyond the initial 2-week period after the injury. This time period was correlated with the period of glial activation and increased glial immunolabeling for TNF-alpha in these eyes. No further protection against neuronal loss was detectable in TNF-R1-/- mice treated with D-JNKI1, a specific inhibitor of c-Jun N-terminal protein kinase (JNK). However, anti-JNK treatment of control animals provided a significant protection against neuronal loss during the same secondary degeneration period. Phospho-JNK immunolabeling of RGCs in control mice subjected to optic nerve crush significantly decreased following their treatment with D-JNKI1, and anti-JNK treatment protected RGCs from degeneration in these animals, similar to the lack of TNF-R1. These findings provide evidence that TNF death receptor signaling is involved in the secondary degeneration of RGCs following optic nerve injury, and is associated with JNK signaling. Since secondarily degenerating neurons are viable targets for neuroprotection, inhibition of TNF death receptor signaling may be an effective strategy to protect RGCs in several neurodegenerative injuries.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14697498     DOI: 10.1016/j.brainres.2003.10.029

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  76 in total

Review 1.  Intrinsic axonal degeneration pathways are critical for glaucomatous damage.

Authors:  Gareth R Howell; Ileana Soto; Richard T Libby; Simon W M John
Journal:  Exp Neurol       Date:  2012-01-18       Impact factor: 5.330

2.  Mechanisms of immune system activation in glaucoma: oxidative stress-stimulated antigen presentation by the retina and optic nerve head glia.

Authors:  Gülgün Tezel; Xiangjun Yang; Cheng Luo; Yong Peng; Sheher L Sun; Deming Sun
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-02       Impact factor: 4.799

3.  Peroxiredoxin 6 delivery attenuates TNF-alpha-and glutamate-induced retinal ganglion cell death by limiting ROS levels and maintaining Ca2+ homeostasis.

Authors:  Nigar Fatma; E Kubo; M Sen; N Agarwal; W B Thoreson; C B Camras; D P Singh
Journal:  Brain Res       Date:  2008-07-29       Impact factor: 3.252

4.  The cell and molecular biology of glaucoma: mechanisms of retinal ganglion cell death.

Authors:  Robert W Nickells
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-04       Impact factor: 4.799

5.  Activation of TLR3 promotes the degeneration of retinal ganglion cells by upregulating the protein levels of JNK3.

Authors:  Shravan K Chintala; Nahrain Putris; Mason Geno
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-01-06       Impact factor: 4.799

6.  Phosphorylation-dependent interaction with 14-3-3 in the regulation of bad trafficking in retinal ganglion cells.

Authors:  Xiangjun Yang; Cheng Luo; Jian Cai; William M Pierce; Gülgün Tezel
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-02-22       Impact factor: 4.799

Review 7.  The role of microglia in the progression of glaucomatous neurodegeneration- a review.

Authors:  Hui-Lan Zeng; Jing-Ming Shi
Journal:  Int J Ophthalmol       Date:  2018-01-18       Impact factor: 1.779

8.  Proinflammatory cytokines in a mouse model of central retinal artery occlusion.

Authors:  Michal Kramer; S Dadon; M Hasanreisoglu; Y Monselise; B R Avraham; A Feldman; I Eldar; D Weinberger; N Goldenberg-Cohen
Journal:  Mol Vis       Date:  2009-05-01       Impact factor: 2.367

9.  Erratum: The two sides of cytokine signaling and glaucomatous optic neuropathy.

Authors:  Ping Huang; Samuel Shao-Min Zhang; Chun Zhang
Journal:  J Ocul Biol Dis Infor       Date:  2009-09-09

10.  The two sides of cytokine signaling and glaucomatous optic neuropathy.

Authors:  Ping Huang; Samuel Shao-Min Zhang; Chun Zhang
Journal:  J Ocul Biol Dis Infor       Date:  2009-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.